NOUVELLES UTILISATIONS

• 收藏
• 分享

专利权人:

INC.;INTRA-CELLULAR THERAPIES

发明人:

WENNOGLE, LAWRENCE P.,DAVIS, ROBERT

申请号：

EP14752171

公开号：

EP2956141A4

申请日:

2014.02.17

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The invention relates to the administration of inhibitors of phosphodiesterase 1 (PDE1) for the treatment of diseases or disorders characterized by disruption of or damage to various cGMP/PKG mediated pathways. In one embodiment the invention relates to inhibitors of phosphodiesterase 1 (PDE1) for treatment of cardiovascular disease and related disorders, e.g., congestive heart disease, atherosclerosis, myocardial infarction, and stroke.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/